Caligo MA - Search Results

1

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.

Couch FJ, Kuchenbaecker KB, Michailidou K, Mendoza-Fandino GA, Nord S, Lilyquist J, Olswold C, Hallberg E, Agata S, Ahsan H, Aittomäki K, Ambrosone C, Andrulis IL, Anton-Culver H, Arndt V, Arun BK, Arver B, Barile M, Barkardottir RB, Barrowdale D, Beckmann L, Beckmann MW, Benitez J, Blank SV, Blomqvist C, Bogdanova NV, Bojesen SE, Bolla MK, Bonanni B, Brauch H, Brenner H, Burwinkel B, Buys SS, Caldes T, Caligo MA, Canzian F, Carpenter J, Chang-Claude J, Chanock SJ, Chung WK, Claes KB, Cox A, Cross SS, Cunningham JM, Czene K, Daly MB, Damiola F, Darabi H, de la Hoya M, Devilee P, Diez O, Ding YC, Dolcetti R, Domchek SM, Dorfling CM, Dos-Santos-Silva I, Dumont M, Dunning AM, Eccles DM, Ehrencrona H, Ekici AB, Eliassen H, Ellis S, Fasching PA, Figueroa J, Flesch-Janys D, Försti A, Fostira F, Foulkes WD, Friebel T, Friedman E, Frost D, Gabrielson M, Gammon MD, Ganz PA, Gapstur SM, Garber J, Gaudet MM, Gayther SA, Gerdes AM, Ghoussaini M, Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Gronwald J, Guénel P, Gunter M, Haeberle L, Haiman CA, Hamann U, Hansen TV, Hart S, Healey S, Heikkinen T, Henderson BE, Herzog J, Hogervorst FB, Hollestelle … See abstract for full author list ➔ Couch FJ, et al. Among authors: caligo ma. Nat Commun. 2016 Apr 27;7:11375. doi: 10.1038/ncomms11375. Nat Commun. 2016. PMID: 27117709 Free PMC article.

2

Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test.

De Benedetti VM, Radice P, Mondini P, Spatti G, Conti A, Illeni MT, Caligo MA, Cipollini G, Bevilaqua G, Pilotti S, Pierotti MA. De Benedetti VM, et al. Among authors: caligo ma. Oncogene. 1996 Sep 19;13(6):1353-7. Oncogene. 1996. PMID: 8808710

3

BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations.

Caligo MA, Ghimenti C, Cipollini G, Ricci S, Brunetti I, Marchetti V, Olsen R, Neuhausen S, Shattuck-Eidens D, Conte PF, Skolnick MH, Bevilacqua G. Caligo MA, et al. Oncogene. 1996 Oct 3;13(7):1483-8. Oncogene. 1996. PMID: 8875986

4

Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium.

Devilee P, Hermans J, Eyfjörd J, Bøorresen AL, Lidereau R, Sobol H, Borg A, Cleton-Jansen AM, Oláh E, Cohen BB, Scherneck S, Hamann U, Peterlin B, Caligo M, Bignon YJ, Maugard C. Devilee P, et al. Genes Chromosomes Cancer. 1997 Mar;18(3):193-9. Genes Chromosomes Cancer. 1997. PMID: 9071572

5

Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.

Phelan CM, Borg A, Cuny M, Crichton DN, Baldersson T, Andersen TI, Caligo MA, Lidereau R, Lindblom A, Seitz S, Kelsell D, Hamann U, Rio P, Thorlacius S, Papp J, Olah E, Ponder B, Bignon YJ, Scherneck S, Barkardottir R, Borresen-Dale AL, Eyfjörd J, Theillet C, Thompson AM, Larsson C, et al. Phelan CM, et al. Among authors: caligo ma. Cancer Res. 1998 Mar 1;58(5):1004-12. Cancer Res. 1998. PMID: 9500463

6

Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.

Neuhausen SL, Godwin AK, Gershoni-Baruch R, Schubert E, Garber J, Stoppa-Lyonnet D, Olah E, Csokay B, Serova O, Lalloo F, Osorio A, Stratton M, Offit K, Boyd J, Caligo MA, Scott RJ, Schofield A, Teugels E, Schwab M, Cannon-Albright L, Bishop T, Easton D, Benitez J, King MC, Ponder BA, Weber B, Devilee P, Borg A, Narod SA, Goldgar D. Neuhausen SL, et al. Among authors: caligo ma. Am J Hum Genet. 1998 Jun;62(6):1381-8. doi: 10.1086/301885. Am J Hum Genet. 1998. PMID: 9585613 Free PMC article.

7

Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group.

Vasen HF, Haites NE, Evans DG, Steel CM, Møller P, Hodgson S, Eccles D, Morrison P, Stoppa Lyonet D, Chang-Claude J, Caligo M. Vasen HF, et al. Eur J Cancer. 1998 Nov;34(12):1922-6. doi: 10.1016/s0959-8049(98)00288-3. Eur J Cancer. 1998. PMID: 10023316

8

Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer.

Chang-Claude J, Becher H, Caligo M, Eccles D, Evans G, Haites N, Hodgson S, Møller P, Weber BH, Stoppa-Lyonnet D. Chang-Claude J, et al. Dis Markers. 1999 Oct;15(1-3):53-65. doi: 10.1155/1999/238375. Dis Markers. 1999. PMID: 10595253 Free PMC article.

9

Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?

Stoppa-Lyonnet D, Caligo M, Eccles D, Evans DG, Haites NE, Hodgson NS, Møller P, Morrison PJ, Steel CM, Vasen HF, Chang-Claude J. Stoppa-Lyonnet D, et al. Dis Markers. 1999 Oct;15(1-3):67-8. doi: 10.1155/1999/239471. Dis Markers. 1999. PMID: 10595254 Free PMC article. No abstract available.

10

Ethical, social and economic issues in familial breast cancer: a compilation of views from the E.C. Biomed II Demonstration Project.

Steel M, Smyth E, Vasen H, Eccles D, Evans G, Møller P, Hodgson S, Stoppa-Lyonnet D, Chang-Claude J, Caligo M, Morrison P, Haites N. Steel M, et al. Dis Markers. 1999 Oct;15(1-3):125-31. doi: 10.1155/1999/564893. Dis Markers. 1999. PMID: 10595265 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

188 results

Search Page